CPRX – catalyst pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
4/16
09:08 am
cprx
Low
Epilepsy Foundation of America Launches Comprehensive Epilepsy & Seizure Safe Classrooms Toolkit for K-12 Educators [Yahoo! Finance]
4/16
01:48 am
cprx
Medium
Santhera shares updates on commercial rollout of AGAMREE® [Yahoo! Finance]
4/11
01:12 pm
cprx
Low
Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Russell 2000 Stock to Buy According to Wall Street Analysts? [Yahoo! Finance]
4/8
08:32 am
cprx
Medium
New Drug Submission for AGAMREE® (vamorolone) Accepted for Priority Review by Health Canada for the Treatment of Duchenne Muscular Dystrophy [Yahoo! Finance]
4/8
08:06 am
cprx
Medium
Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals
2/26/2025
04:13 pm
CPRX
-0.7%
BEAT
2/26/2025
04:13 pm
CPRX
-0.7%
BEAT
2/26/2025
04:13 pm
CPRX
-0.7%
BEAT
2/26/2025
04:13 pm
CPRX
-0.7%
BEAT
3/3
07:44 am
Maintains
Outperform
Outperform
Baird
Low
-2.6%
3/3
07:44 am
Maintains
Outperform
Outperform
Baird
Low
-2.6%
2/28
09:31 am
Reiterates
Buy
Buy
HC Wainwright
Medium
5.5%
2/27
09:51 am
Reiterates
Overweight
Overweight
Stephens
Medium
-6.1%
2/27
09:51 am
Reiterates
Overweight
Overweight
Stephens
Medium
-6.1%
4/14
05:19 pm
cprx
Low
Form ARS CATALYST PHARMACEUTICALS For: Dec 31
4/11
05:44 pm
cprx
Medium
Form DEF 14A CATALYST PHARMACEUTICALS For: May 20
4/9
08:55 am
cprx
Medium
Form 8-K CATALYST PHARMACEUTICALS For: Apr 08
3/7
05:00 pm
cprx
Medium
Form 4 CATALYST PHARMACEUTICALS For: Mar 05 Filed by: INGENITO GARY
3/6
04:52 pm
cprx
Low
Form 144 CATALYST PHARMACEUTICALS Filed by: INGENITO GARY
Show more
Top News Gainers
5/9 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. 15.9%
5/14 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was given a new $9.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. 12.7%
4/8 Catalyst Pharmaceuticals Provides Update on Impact of COVID-19 Pandemic on its Business Activities 11.5%
1/6 Catalyst Pharmaceuticals Pre-Announces Estimated Firdapse® Revenues and Provides Updates on Advancement of Clinical Development Programs 11.1%
3/10 Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End Financial Results and Corporate Update Conference Call and Webcast on Tuesday, March 17th, 2020 9.8%
2/5 Form 8-K CATALYST PHARMACEUTICALS For: Feb 04 9.5%
3/16 Q4/2019 12/31/2019 EPS 0.070 ZacksConsensus 0.090 ActVsEst (0.020) - Miss 8.6%
6/12 Catalyst Pharmaceuticals Files Federal Lawsuit Against U.S. Food and Drug Administration 7.9%
11/13 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) had its price target lowered by analysts at Piper Jaffray Companies from $8.00 to $7.00. 5.6%
9/24 Form 8-K CATALYST PHARMACEUTICALS For: Sep 23 5.5%
Top News Decliners
3/15 Catalyst Pharmaceuticals Q4 2019 Earnings Preview [Seeking Alpha] -23.2%
9/11 Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock -14.9%
10/30 Catalyst Pharmaceuticals Announces Top-Line Results of CMS-001, a Phase 3 Trial of Firdapse® (Amifampridine Phosphate) in Patients with Congenital Myasthenic Syndromes (CMS) -14.5%
4/14 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -12.1%
5/13 Form 8-K CATALYST PHARMACEUTICALS For: May 13 -11.7%
8/7 Q2/2019 6/30/2019 EPS 0.100 ZacksConsensus 0.030 ActVsEst 0.070 - Beat -10.7%
2/27 Catalyst Pharmaceuticals Announces Support of Rare Disease Day 2020 -10.3%
12/20 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -8.9%
9/13 Form 8-K CATALYST PHARMACEUTICALS For: Sep 13 -8.0%
11/12 Form 10-Q CATALYST PHARMACEUTICALS For: Sep 30 -7.3%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3